Home Palliative Care for Dementia
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Home Palliative Care for Dementia?
Is home palliative care safe for people with dementia?
How is the Home Palliative Care treatment different from other treatments for dementia?
Home Palliative Care for dementia is unique because it focuses on providing holistic support to both the person with dementia and their family in their own home, addressing not just medical needs but also emotional and social aspects. This approach is different from traditional treatments that may focus more on medication and less on the overall well-being and quality of life of the patient and their family.19101112
What is the purpose of this trial?
A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York City, patients with advanced dementia and their family caregivers will be randomized to intervention or augmented control.
Research Team
Laura P Gelfman, MD, MPH
Principal Investigator
Icahn School of Medicine at Mount Sinai
Eligibility Criteria
This trial is for patients over 64 years old with advanced dementia (GDS > 6) living in Manhattan, not in long-term care. They must have had a hospital visit within the last year and have a primary physician from one of the four Mount Sinai sites. A family caregiver must be willing to enroll and either patient or caregiver should speak English or Spanish.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intake and Care Plan Development
An intake visit is conducted by the clinical team to develop a care plan based on clinical needs
Ongoing Monitoring and Support
Participants receive ongoing monitoring and support through telephone, video, and in-person visits, with access to a 24-hour advice line
Follow-up
Participants are monitored for healthcare utilization and caregiver outcomes
Treatment Details
Interventions
- Home Palliative Care
Home Palliative Care is already approved in United States for the following indications:
- Symptom management for advanced dementia
- Support for family caregivers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
National Institute on Aging (NIA)
Collaborator